Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of hyperthermic intraperitoneal chemotherapy at time of secondary cytoreductive surgery on immediate platinum resistance: A Memorial Sloan Kettering team ovary study
    Meeting Abstract

    Praiss, A.; Donohoe, F.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Broach, V.; Al-Niaimi, A.; Gardner, G.; Roche, K. L.; O'Cearbhaill, R.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Long survival in patients with adnexal high-grade serous carcinoma who underwent suboptimal cytoreductive surgery: A whole-genome analysis
    Meeting Abstract

    Sullivan, M.; Brown, D.; Paula, A. D.; Boerner, T.; O'Cearbhaill, R.; Tew, W.; Grisham, R.; Sonoda, Y.; Leitao, M.; Broach, V.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Monitoring response to immune checkpoint inhibition in patients with endometrial cancer using cell-free DNA analysis
    Meeting Abstract

    Manning-Geist, B.; Patel, J.; Marra, A.; Zammarrelli, W. A. 3rd; Da Cruz Paula, A.; Abu-Rustum, N.; Shah, R.; Berger, M.; Hensley, M.; Lakhman, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53WT advanced or recurrent endometrial cancer: Follow up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Fidalgo, J. A. P.; Vergote, I.; Hamilton, E.; Giorgi, U. D.; Gorp, T. V.; Lübbe, K.; Zikan, M.; Helpman, L.; Miller, D. S.; Fariñas-Madrid, L.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial
    Meeting Abstract

    You, B.; Anderson, C.; Cecere, S. C.; Carrot, A.; Myers, T.; Heitz, F.; Sudarshan, S.; Selcukbiricik, F.; Aghajanian, C.; Fernebro, J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of therapy in patients with recurrent low-grade serous ovarian cancer: GOG-3097/ENGOT-ov81/NCRI/RAMP 301
    Meeting Abstract

    Grisham, R.; Monk, B.; Van Nieuwenhuysen, E.; Moore, K.; Fabbro, M.; O'Malley, D.; Oaknin, A.; Thaker, P.; Oza, A.; Colombo, N.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Randomized, phase II/III study of pegylated liposomal doxorubicin, bevacizumab, and atezolizumab in platinum-resistant ovarian cancer (NRG-GY009): Clinical outcomes by PD-L1 and T cell infiltration status
    Meeting Abstract

    O'Cearbhaill, R.; Zamarin, D.; Sill, M.; Duong, H.; Waggoner, S.; Grisham, R.; Backes, F.; Mannel, R.; Tanyi, J.; Powell, M.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201
    Meeting Abstract

    Banerjee, S.; Aghajanian, C.; Van Nieuwenhuysen, E.; Santin, A.; Ring, K.; Colombo, N.; Thaker, P.; Prendergast, E.; Moore, K.; Chon, H. S.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors
    Meeting Abstract

    Sanborn, R. E.; Patel, M. R.; Rodon, J.; Thein, K. Z.; Friedman, C.; Levitz, D.; Ngirailemesang, I.; Goodman, A.; Agarwal, P.; Friedman, E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save